Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients

Eva Boysen Fynboe Ebert, Tine McCulloch, Karin Holmskov Hansen, Hanne Linnet, Boe Sorensen, Peter Meldgaard

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

OriginalsprogEngelsk
TidsskriftLung Cancer
Vol/bind143
Sider (fra-til)67-72
Antal sider6
ISSN0169-5002
DOI
StatusUdgivet - maj 2020

Fingeraftryk Dyk ned i forskningsemnerne om 'Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients'. Sammen danner de et unikt fingeraftryk.

Citationsformater